Intensive haemodialysis using PMMA dialyser does not increase renal response rate in multiple myeloma patients with acute kidney injury

BACKGROUND: Intensive haemodialysis (IHD) in addition to bortezomib-based chemotherapy might be efficient to rapidly decrease serum immunoglobulin-free light chains removal in patients with multiple myeloma (MM) and to improve renal prognosis and survival. METHODS: The aim of this retrospective mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Hudier, Laurent, Decaux, Olivier, Haddj-Elmrabet, Atmann, Lino, Marie, Mandart, Lise, Siohan, Pascale, Renaudineau, Eric, Sawadogo, Theophile, Lamy De La Chapelle, Thierry, Oger, Emmanuel, Bridoux, Frank, Vigneau, Cécile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Onconephrology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887381/
https://www.ncbi.nlm.nih.gov/pubmed/29644064
http://dx.doi.org/10.1093/ckj/sfx079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887381/
https://www.ncbi.nlm.nih.gov/pubmed/29644064
http://dx.doi.org/10.1093/ckj/sfx079

Ejemplares similares